Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDER Guidance Agenda 2004: Pregnancy, Pediatric Studies Are Priorities

Executive Summary

FDA is planning several new guidances to refine recommendations for drug studies in children and pregnant women during 2004, the Center for Drug Evaluation & Research's guidance agenda for the coming year indicates

You may also be interested in...



Pregnancy Adverse Events Could Be Shown Separately Under Labeling Reform

Pregnancy-related labeling reforms could include displaying birth defect incidence information in a separate section from general adverse events, Center for Drug Evaluation & Research Office of New Drugs Pregnancy Labeling Team Leader Kathleen Uhl, MD, suggested

Pregnancy Adverse Events Could Be Shown Separately Under Labeling Reform

Pregnancy-related labeling reforms could include displaying birth defect incidence information in a separate section from general adverse events, Center for Drug Evaluation & Research Office of New Drugs Pregnancy Labeling Team Leader Kathleen Uhl, MD, suggested

FDA Assessing QT Study Designs With Clinical Trial Simulations

FDA hopes to use clinical trial simulations to develop study designs to more accurately predict drugs' QT prolongation risk

Related Content

UsernamePublicRestriction

Register

PS043290

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel